Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1922 1
1923 1
1928 2
1947 1
1948 1
1951 1
1953 2
1958 1
1960 1
1961 2
1963 3
1964 2
1965 3
1966 5
1967 6
1968 13
1969 8
1970 1
1971 3
1972 5
1973 4
1974 4
1975 4
1976 2
1977 4
1978 4
1979 2
1980 5
1981 10
1982 4
1983 3
1984 2
1985 5
1986 4
1987 16
1988 5
1989 8
1990 10
1991 12
1992 9
1993 21
1994 8
1995 11
1996 12
1997 14
1998 12
1999 14
2000 18
2001 19
2002 19
2003 17
2004 17
2005 30
2006 37
2007 41
2008 33
2009 28
2010 29
2011 35
2012 48
2013 54
2014 59
2015 58
2016 67
2017 64
2018 98
2019 104
2020 95
2021 112
2022 108
2023 100
2024 101
2025 62

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,551 results

Results by year

Filters applied: . Clear all
Page 1
From Tool to Teammate: A Randomized Controlled Trial of Clinician-AI Collaborative Workflows for Diagnosis.
Everett SS, Bunning BJ, Jain P, Lopez I, Agarwal A, Desai M, Gallo R, Goh E, Kadiyala VB, Kanjee Z, Koshy JM, Olson A, Rodman A, Schulman K, Strong E, Chen JH, Horvitz E. Everett SS, et al. Among authors: olson a. medRxiv [Preprint]. 2025 Jun 8:2025.06.07.25329176. doi: 10.1101/2025.06.07.25329176. medRxiv. 2025. PMID: 40502554 Free PMC article. Preprint.
Determining preclinical safety of Aclarubicin in pediatric malignancies.
Tu DS, Olson AK, Waggie KS, Garcia NM, Hoglund VJ, Walter S, Rosinski JR, Sadeeshkumar H, Patel R, Sayar E, Haffner MC, Maves L, Neefjes J, Sarthy JF, Lawlor ER, Ganapathi SS. Tu DS, et al. Among authors: olson ak. bioRxiv [Preprint]. 2025 May 24:2025.05.20.654130. doi: 10.1101/2025.05.20.654130. bioRxiv. 2025. PMID: 40475456 Free PMC article. Preprint.
The effects of clinically relevant radionuclides on the activation of a type I interferon response correlate with radionuclide half-life and linear energy transfer and influence radiopharmaceutical antitumor efficacy.
Kerr CP, Sheehan-Klenk J, Grudzinski JJ, Adam DP, Nguyen TPT, Ferreira CA, Bates AM, Jin WJ, Kwon O, Olson AP, Lin W, Hyun M, Jagodinsky JC, Powers M, Sriramaneni RN, Clark PA, Shea AG, Comas Rojas H, Choi C, Massey CF, Zangl LM, Pinchuk AN, Aluicio-Sarduy E, Kim K, Engle JW, Hernandez R, Bednarz BP, Weichert JP, Morris ZS. Kerr CP, et al. Among authors: olson ap. Cancer Immunol Res. 2025 May 29. doi: 10.1158/2326-6066.CIR-24-1191. Online ahead of print. Cancer Immunol Res. 2025. PMID: 40439704
Call to Action: Lead Pharmacy into the Next Decade.
Zumach G, Fierke KK, Lepp G, McGugan B, Brooks MJ, Olson A, Bartlett A, Karunaratne N, Exintaris B. Zumach G, et al. Among authors: olson a. Innov Pharm. 2025 Jan 14;15(4):10.24926/iip.v15i4.6265. doi: 10.24926/iip.v15i4.6265. eCollection 2024. Innov Pharm. 2025. PMID: 40401294 Free PMC article. No abstract available.
1,551 results